Clair Health Secures $11.6 Million Investment Led By Khosla Ventures For Hormonal Health Device

Clair Health has raised $11.6 million in a funding round led by Khosla Ventures, with participation from several investors including a16z Speedrun, Brydge Club, Treehub, Cartan Capital, AGI House, Insiders VC, Anne Wojcicki, and Stephanie Coleman. The investment will support the expansion of the company's closed beta testing and the broader launch of its noninvasive wearable device priced at $369, which aims to track hormonal health through various biomarkers.

Summary of transaction details:

• Deal Type: Investment
• Transaction Amount: $11,600,000
• Company Name: Clair Health
• Headquarters: Mountain View, California
• Founders: Jenny Duan and Abhinav Agarwal
• Notable Investors: Khosla Ventures, a16z Speedrun, Brydge Club, Treehub, Cartan Capital, AGI House, Insiders VC, Anne Wojcicki, Stephanie Coleman

Clair Health is focused on women's health and is developing a wearable device that tracks hormonal health using biomarkers like inflammation, bloating, energy levels, and cycle phase classification. The device integrates voice-based onboarding and employs AI models for interpreting conversational inputs related to hormonal states, contributing to a comprehensive health management solution.